Forecasts data is unavailable for this security.
Consensus recommendation
- 18-May-23
- 15-Feb-24
- 14-Mar-24
- 18-Apr-24
- 25-Apr-24
Select bar for recommendation details.
Recommendations | 25-Apr-24 | |
---|---|---|
Buy | 4 | |
Outperform | 2 | |
Hold | 6 | |
Underperform | 0 | |
Sell | 0 |
Share price forecast in USD
The 10 analysts offering 12 month price targets for Hikma Pharmaceuticals Plc have a median target of 2,357.37, with a high estimate of 5,199.81 and a low estimate of 2,000.17. The median estimate represents a 23.23% increase from the last price of 1,913.00.
High | 171.8% | 5,199.81 |
Med | 23.2% | 2,357.37 |
Low | 4.6% | 2,000.17 |
Dividends in USD
Div growth (TTM) | 30.11% |
---|
More ▼
Earnings history & estimates in USD
Average growth rate | +10.73% |
More ▼
Revenue history & estimates in USD
Average growth rate | +6.99% |
More ▼